{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ORINF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORINF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORINF\",,,,,undefined,":{"symbol":"ORINF","market":"US","secType":"STK","nameCN":"Orion Corporation OY","latestPrice":48.65,"timestamp":1749758400000,"preClose":48.65,"halted":0,"volume":0,"delay":15,"floatShares":121619731,"shares":140501423,"eps":1.661351,"marketStatus":"Pre-Mkt","change":0,"latestTime":"06-12 16:00:00 EDT Delay","open":48.65,"high":48.65,"low":48.65,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":1.661351,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749821400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":48.65,"volumeRatio":1.3666199765522704},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORINF\",,,,,undefined,":{"symbol":"ORINF","floatShares":121619731,"roa":"15.58%","roe":"39.16%","lyrEps":1.707711,"volumeRatio":1.3666199765522704,"shares":140501423,"dividePrice":1.886184,"high":48.65,"amplitude":0,"preClose":48.65,"low":48.65,"week52Low":47.16,"pbRate":"5.57","psRate":"3.74","week52High":48.65,"institutionHeld":0,"latestPrice":48.65,"eps":1.661351,"divideRate":0.03877,"volume":0,"delay":15,"ttmEps":1.661351,"open":48.65,"prevYearClose":48.65,"prevWeekClose":48.65,"prevMonthClose":48.65,"prevQuarterClose":48.65,"fiveDayClose":48.65,"twentyDayClose":48.65,"sixtyDayClose":48.65},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ORINF\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ORINF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532867212","title":"301,521 Orion Corporation A shares converted into B shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2532867212","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532867212?lang=en_us&edition=fundamental","pubTime":"2025-05-02 14:00","pubTimestamp":1746165600,"startTime":"0","endTime":"0","summary":"ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE2 MAY 2025 at 9.00 EEST. In accordance with Section 3 of the Articles of Association of Orion Corporation, 301,521 A shares have been converted into 301,521 B shares. The conversion has been entered into the Trade Register on 2 May 2025.The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 32,450,742 A shares and 108,683,536 B shares. The number of votes of the company's shares is after the conversion 757,698,376.Orion is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products develope","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/301-521-orion-corporation-shares-060000283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ORINF","ORINY"],"gpt_icon":0},{"id":"2530155013","title":"Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530155013","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530155013?lang=en_us&edition=fundamental","pubTime":"2025-04-25 22:20","pubTimestamp":1745590800,"startTime":"0","endTime":"0","summary":"ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS25 April 2025 at 17.20 EEST. Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 24 April 2025 above five  per cent of Orion Corporation’s total shares.Total positions of BlackRock, Inc. and its funds subject to notification:. % of shares and voting rights through financial instruments . Total number of shares and voting rights of issuer. Resulting situation on the date on which threshold was crossed or reached. Notified details of the resulting situation on the date on which the threshold was crossed:. Point B: Financial instruments according to SMA 9:6a:. Contact person:Tuukka Hirvonen, Investor Relations, Orion Corporationtel. +358 10426 2721. Orion is a globally operating Finnish pharmaceutical company – ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/orion-corporation-disclosure-under-chapter-142000257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2430703095.HKD","LU0070302665.USD","LU2505996681.GBP","LU1280957306.USD","LU1481011671.HKD","LU0731783394.SGD","ORINY","BK4535","LU2430703251.USD","LU1201861249.SGD","LU0208291251.USD","LU2505996509.AUD","LU1074936037.SGD","BK4504","LU2592432038.USD","IE00B3QW5Z07.USD","IE00B42XCP33.USD","BK4534","LU0320765489.SGD","LU1481011911.USD","LU1988902786.USD","LU2430703178.SGD","BK4581","IE00B3PB1722.GBP","BK4135","IE00BVYPNW00.USD","LU0980610538.SGD","BK4007","LU1670628061.USD","LU1064131342.USD","LU1989771016.USD","LU0130102774.USD","ORINF","LU1599440770.SGD","IE00BGHQF748.EUR","IE00BDGV0183.EUR","LU1670627923.USD","BK4567","LU0772969993.USD","BK4585","IE00BGHQF631.EUR","IE00BVYPNV92.GBP","LU0731783048.USD","BK4533","LU1509826696.USD","LU2264538146.SGD","IE00B64PRP62.GBP","LU0742537680.HKD","LU0640476718.USD","BLK","LU1291159041.SGD"],"gpt_icon":0},{"id":"2530921513","title":"Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2530921513","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530921513?lang=en_us&edition=fundamental","pubTime":"2025-04-25 14:00","pubTimestamp":1745560800,"startTime":"0","endTime":"0","summary":"ORION CORPORATION PRESS RELEASE 25 APRIL 2025 at 9.00 EEST. Orion and Criceto Announce a License Agreement for APORON, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease. Orion Corporation  and Criceto IKM B.V.  today announced the signing of an exclusive license agreement for the development and commercialization of APORON, a novel apomorphine oromucosal spray for the treatment of OFF episodes in patients with Parkinson’s disease. APORON is currently in Phase 3 development by Criceto.Orion is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/orion-criceto-announce-license-agreement-060000485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ORINY","BK4007","ORINF"],"gpt_icon":0},{"id":"2530515921","title":"European Dividend Stocks To Consider In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530515921","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530515921?lang=en_us&edition=fundamental","pubTime":"2025-04-25 13:31","pubTimestamp":1745559112,"startTime":"0","endTime":"0","summary":"As European markets show signs of recovery, buoyed by the European Central Bank's interest rate cuts and a delay in tariff increases, investors are increasingly looking towards dividend stocks as a source of steady income amid economic uncertainty. In this environment, selecting dividend stocks with strong fundamentals and resilient cash flows can be an effective strategy for those seeking to navigate market volatility while pursuing long-term growth.Click here to see the full list of 245 stocks from our Top European Dividend Stocks screener.Operations: Orion Oyj's revenue is derived from its operations in developing, manufacturing, and marketing pharmaceuticals for both humans and animals, as well as active pharmaceutical ingredients , across various regions including Finland, Scandinavia, Europe, North America, and other international markets.Overview: New Wave Group AB  operates by designing, acquiring, and developing brands and products across corporate, sports, gifts, and home fur","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-dividend-stocks-consider-april-053152965.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ORINY","ORINF"],"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORINF\",params:#limit:5,,,undefined,":[{"date":"2025-04-04","symbol":"ORINF","amount":0.82,"announcedDate":"2025-02-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-07","defaultRemindTime":1743773400000,"name":"Orion Corporation OY","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-14","payableDate":"2025-04-07","currency":"EUR","dateTimestamp":1743739200000,"payDate":"2025-04-14"},{"date":"2024-10-15","symbol":"ORINF","amount":0.81,"announcedDate":"2024-02-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-10-16","defaultRemindTime":1728999000000,"name":"Orion Corporation OY","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-23","payableDate":"2024-10-16","currency":"EUR","dateTimestamp":1728964800000,"payDate":"2024-10-23"},{"market":"US","date":"2024-04-25","symbol":"ORINF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"pre","actualEps":null},{"date":"2024-03-21","symbol":"ORINF","amount":0.81,"announcedDate":"2024-02-13","type":"dividend","market":"US","newRecordDate":"2024-03-22","defaultRemindTime":1711027800000,"name":"Orion Corporation OY","recordDate":"2024-04-03","payableDate":"2024-03-22","currency":"EUR","dateTimestamp":1710993600000,"payDate":"2024-04-03"},{"market":"US","date":"2023-03-23","symbol":"ORINF","amount":1.6,"defaultRemindTime":1679578200000,"name":"Orion Corporation OY","recordDate":"2023-03-31","payableDate":"2023-03-24","currency":"EUR","type":"dividend","dateTimestamp":1679544000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORINF\",market:\"US\",,,undefined,":[{"executeDate":"2019-03-27","recordDate":"2019-03-28","paymentDate":"2019-04-04","value":1.5,"currency":"EUR"},{"executeDate":"2020-03-26","recordDate":"2020-03-27","paymentDate":"2020-04-03","value":1.5,"currency":"EUR"},{"executeDate":"2020-05-07","recordDate":"2020-05-08","paymentDate":"2020-05-15","value":1.5,"currency":"EUR"},{"executeDate":"2021-03-26","recordDate":"2021-03-29","paymentDate":"2021-04-07","value":1.5,"currency":"EUR"},{"executeDate":"2022-03-24","recordDate":"2022-03-25","paymentDate":"2022-04-01","value":1.5,"currency":"EUR"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORINF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.2857,"hold":0.1429,"sell":0.2857,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1745553600000}}}